成人2型糖尿病治疗药物Jentadueto获FDA批准

2012-02-17 MedSci MedSci原创

勃林格殷格翰公司和礼来公司近日(NYSE: LLY)宣布Jentadueto(linagliptin/盐酸二甲双胍)片已经获得了美国食品和药品管理局 (FDA)的批准，该药是二肽基肽酶-4 (DPP-4)抑制剂 linagliptin和二甲双胍的新型复合片剂1。Linagliptin/盐酸二甲双胍的问世为需要改善血糖控制的2型糖尿病成年患者提供了全新的、每日服用两次的单一药片治疗选择1。 Lina

勃林格殷格翰公司和礼来公司近日(NYSE: LLY)宣布Jentadueto(linagliptin/盐酸二甲双胍)片已经获得了美国食品和药品管理局 (FDA)的批准，该药是二肽基肽酶-4 (DPP-4)抑制剂 linagliptin和二甲双胍的新型复合片剂1。Linagliptin/盐酸二甲双胍的问世为需要改善血糖控制的2型糖尿病成年患者提供了全新的、每日服用两次的单一药片治疗选择1。 Linagliptin (5 mg，每日给药一次)已经在美国以Tradjenta? (linagliptin)片的形式上市，在欧洲和加拿大则以Trajenta? 为商品名上市，在日本和其他市场则以 Trazenta? 为商品名上市2,3，目前在中国尚未上市。

Linagliptin/盐酸二甲双胍治疗应基于饮食控制和体育锻炼之上，这一处方药物可应用于适合接受linagliptin和二甲双胍治疗的2型糖尿病成年患者，用以改善这些患者的血糖控制水平。在使用最大给药剂量的时候，linagliptin/盐酸二甲双胍可使得安慰剂校正的血红蛋白A1c（HbA1c 或 A1C）出现高达1.7%的降幅 (安慰剂组为+0.1%，linagliptin/盐酸二甲双胍组为-1.6%)。A1C 是糖尿病检测指标之一，可反映最近2个月到3个月的血糖控制水平。Linagliptin/盐酸二甲双胍不会导致任何具有临床意义的体重改变。Linagliptin/盐酸二甲双胍可单独使用，也可与2型糖尿病常用药物磺脲类药物联合使用。Linagliptin/盐酸二甲双胍不应用于1型糖尿病或糖尿病酮症酸中毒 (血液或尿液中的酮体含量增高)，目前尚未对该药与胰岛素的联合使用开展过研究。Linagliptin/盐酸二甲双胍的产品标签中包含有关乳酸酸中毒的加框警示，乳酸酸中毒是一种严重的代谢性并发症，由linagliptin/盐酸二甲双胍治疗过程中产生的二甲双胍蓄积所导致1。

“由于2型糖尿病具有复杂的发病机制，大多数2型糖尿病患者需要接受一种以上的药物治疗以降低其血糖水平，”来自德州肾脏和内分泌疾病研究所的 Lance Sloan博士如此说道。“Jentadueto? 获得批准是一个令人兴奋的消息，因为这种药物将两种降糖药复合成为单一片剂，从而为那些需要一种以上药物治疗、而且适合接受linagliptin和二甲双胍的患者提供了很好的治疗选择。”

拓展阅读：

FDA批准默克Janumet缓释片用于治疗2型糖尿病

FDA批准缓释艾塞那肽获准抗II型糖尿病

成人2型糖尿病治疗药物Jentadueto获FDA批准

糖尿病新药Dapagliflozin被FDA否决

LX4211联合西他列汀治疗糖尿病临床研究完成

糖尿病新药研究动态汇集（附点评）

DPP-4抑制剂：破解2型糖尿病的治疗困境

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1989900, encodeId=74d6198990014, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76735, encryptionId=3207e6735ae, topicName=糖尿病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Tue Dec 18 03:34:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1839137, encodeId=5029183913e8e, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Sep 03 08:34:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040438, encodeId=e3af2040438d5, content=<a href='/topic/show?id=1e3c1028697' target=_blank style='color:#2F92EE;'>#Jentadueto#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10286, encryptionId=1e3c1028697, topicName=Jentadueto)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 03 03:34:00 CST 2012, time=2012-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921590, encodeId=688219215903e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Mar 23 15:34:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302995, encodeId=04f21302995f0, content=<a href='/topic/show?id=db455381944' target=_blank style='color:#2F92EE;'>#成人2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53819, encryptionId=db455381944, topicName=成人2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65c7309, createdName=fengxx, createdTime=Sun Feb 19 09:34:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
2012-12-18 zhanglin3079

#糖尿病治疗#

77 0
[GetPortalCommentsPageByObjectIdResponse(id=1989900, encodeId=74d6198990014, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76735, encryptionId=3207e6735ae, topicName=糖尿病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Tue Dec 18 03:34:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1839137, encodeId=5029183913e8e, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Sep 03 08:34:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040438, encodeId=e3af2040438d5, content=<a href='/topic/show?id=1e3c1028697' target=_blank style='color:#2F92EE;'>#Jentadueto#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10286, encryptionId=1e3c1028697, topicName=Jentadueto)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 03 03:34:00 CST 2012, time=2012-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921590, encodeId=688219215903e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Mar 23 15:34:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302995, encodeId=04f21302995f0, content=<a href='/topic/show?id=db455381944' target=_blank style='color:#2F92EE;'>#成人2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53819, encryptionId=db455381944, topicName=成人2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65c7309, createdName=fengxx, createdTime=Sun Feb 19 09:34:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
2012-09-03 bugit

#FDA批准#

65 0
[GetPortalCommentsPageByObjectIdResponse(id=1989900, encodeId=74d6198990014, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76735, encryptionId=3207e6735ae, topicName=糖尿病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Tue Dec 18 03:34:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1839137, encodeId=5029183913e8e, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Sep 03 08:34:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040438, encodeId=e3af2040438d5, content=<a href='/topic/show?id=1e3c1028697' target=_blank style='color:#2F92EE;'>#Jentadueto#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10286, encryptionId=1e3c1028697, topicName=Jentadueto)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 03 03:34:00 CST 2012, time=2012-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921590, encodeId=688219215903e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Mar 23 15:34:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302995, encodeId=04f21302995f0, content=<a href='/topic/show?id=db455381944' target=_blank style='color:#2F92EE;'>#成人2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53819, encryptionId=db455381944, topicName=成人2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65c7309, createdName=fengxx, createdTime=Sun Feb 19 09:34:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
2012-05-03 zhaohui6731

#Jentadueto#

65 0
[GetPortalCommentsPageByObjectIdResponse(id=1989900, encodeId=74d6198990014, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76735, encryptionId=3207e6735ae, topicName=糖尿病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Tue Dec 18 03:34:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1839137, encodeId=5029183913e8e, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Sep 03 08:34:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040438, encodeId=e3af2040438d5, content=<a href='/topic/show?id=1e3c1028697' target=_blank style='color:#2F92EE;'>#Jentadueto#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10286, encryptionId=1e3c1028697, topicName=Jentadueto)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 03 03:34:00 CST 2012, time=2012-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921590, encodeId=688219215903e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Mar 23 15:34:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302995, encodeId=04f21302995f0, content=<a href='/topic/show?id=db455381944' target=_blank style='color:#2F92EE;'>#成人2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53819, encryptionId=db455381944, topicName=成人2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65c7309, createdName=fengxx, createdTime=Sun Feb 19 09:34:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
2012-03-23 周虎

#治疗药物#

80 0
[GetPortalCommentsPageByObjectIdResponse(id=1989900, encodeId=74d6198990014, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76735, encryptionId=3207e6735ae, topicName=糖尿病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Tue Dec 18 03:34:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1839137, encodeId=5029183913e8e, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Sep 03 08:34:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040438, encodeId=e3af2040438d5, content=<a href='/topic/show?id=1e3c1028697' target=_blank style='color:#2F92EE;'>#Jentadueto#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10286, encryptionId=1e3c1028697, topicName=Jentadueto)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 03 03:34:00 CST 2012, time=2012-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921590, encodeId=688219215903e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Mar 23 15:34:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302995, encodeId=04f21302995f0, content=<a href='/topic/show?id=db455381944' target=_blank style='color:#2F92EE;'>#成人2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53819, encryptionId=db455381944, topicName=成人2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65c7309, createdName=fengxx, createdTime=Sun Feb 19 09:34:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
2012-02-19 fengxx

#成人2型糖尿病#

60 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

糖尿病

成人2型糖尿病治疗药物Jentadueto获FDA批准

相关资讯

科室

工具

服务